Weill Cornell Medicine's Englander Institute for Precision Medicine is a large multi-disciplinary institute that uses precision medicine technologies and informatics to uncover the molecular mechanisms of disease and individualize disease treatment and prevention.
Dear Members of the Englander Institute,
Thank you all for a very productive January!
A diagnosis of pancreatic cancer usually means a quick death—but not for Roger Royse, who was in Stage II of the disease when he got the bad news in July 2022. The five-year relative survival rate for late-stage metastatic pancreatic cancer is 3%—which means that patients are 3% as likely to live five years after their diagnosis as other cancer-free individuals.
A multidisciplinary task force of Cornell faculty and staff has issued a report offering perspectives and practical guidelines for the use of generative artificial intelligence (GenAI) in the practice and dissemination of Cornell’s academic research.